Ottawa Hospital Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 2001-01-01

Employees: 5K

Market Cap: -

Website: http://www.ohri.ca

Clinical Trials

Micronutrients and Antioxidants in HIV Infection

Not Applicable

Completed

Conditions: HIV Infection

Interventions: Dietary Supplement: Multivitamins and minerals
Dietary Supplement: Micronutrients and antioxidants

First Posted Date: 2008-11-26

Last Posted Date: 2018-04-17

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 171

Registration Number: NCT00798772

Locations: 🇨🇦
The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada

Low Dose Supplementation to Improve Anticoagulation Control With Oral Vitamin K as an Adjuvant to Warfarin Therapy

Phase 3

Completed

Conditions: Coagulation

Interventions: Dietary Supplement: Vitamin K1 (Phytonadione)
Dietary Supplement: Placebo

First Posted Date: 2008-11-20

Last Posted Date: 2011-07-27

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 100

Registration Number: NCT00794755

Locations: 🇨🇦
Ottawa Hospital Thrombosis Clinic, Ottawa, Ontario, Canada

TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial

Phase 2

Completed

Conditions: COPD Exacerbation

Interventions: Drug: Etanercept
Drug: Prednisone
Drug: levofloxacin

First Posted Date: 2008-11-13

Last Posted Date: 2016-04-11

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 81

Registration Number: NCT00789997

Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

Completed

Conditions: Venous Thromboembolism

First Posted Date: 2008-11-11

Last Posted Date: 2016-10-27

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 2537

Registration Number: NCT00788736

Locations: 🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada
🇨🇦
Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
🇺🇸
Lahey Clinic, Burlington, Massachusetts, United States

and more 9 locations

Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer

Phase 1

Completed

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: sorafenib + FOLFIRI

First Posted Date: 2008-10-27

Last Posted Date: 2013-05-13

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 16

Registration Number: NCT00780169

Locations: 🇨🇦
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

Advanced Surface Ablation (ASA) vs Laser-Assisted In Situ Keratomileusis (LASIK)

Conditions: Nearsightedness
Farsightedness
Astigmatism

First Posted Date: 2008-10-23

Last Posted Date: 2014-12-02

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 4000

Registration Number: NCT00778570

Locations: 🇨🇦
University of Ottawa Eye Institute, Ottawa, Ontario, Canada

Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism

Not Applicable

Completed

Conditions: Venous Thromboembolism
Deep Vein Thrombosis
Pulmonary Embolism

Interventions: Device: Comprehensive computed tomography of the abdomen/pelvis
Other: Limited Malignancy Screening

First Posted Date: 2008-10-16

Last Posted Date: 2015-07-07

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 862

Registration Number: NCT00773448

Locations: 🇨🇦
St. Boniface Hospital, Winnipeg, Manitoba, Canada
🇨🇦
London Health Sciences Center, London, Ontario, Canada
🇨🇦
St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada

and more 6 locations

Influenza Vaccine in HIV

Phase 3

Completed

Conditions: Influenza
HIV

Interventions: Biological: Fluviral

First Posted Date: 2008-10-02

Last Posted Date: 2017-04-28

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 285

Registration Number: NCT00764998

Locations: 🇨🇦
McMaster University Medical Center, Hamilton, Ontario, Canada
🇨🇦
Infectious Disease Care Program, London, Ontario, Canada
🇨🇦
University of Ottawa Health Services, Toronto, Ontario, Canada

and more 10 locations

Conventional Hemodialysis vs. Short Daily Hemodialysis (6 Days / Week) and Mechanisms of Blood Pressure Control

Not Applicable

Completed

Conditions: End Stage Renal Disease

Interventions: Procedure: Microneurography
Procedure: Bioimpedance testing

First Posted Date: 2008-09-25

Last Posted Date: 2017-08-04

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 22

Registration Number: NCT00759967

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

Follow-up Care After Treatment for Endometrial Cancer

Completed

Conditions: Endometrial Neoplasm

First Posted Date: 2008-09-10

Last Posted Date: 2012-07-13

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 20

Registration Number: NCT00750672

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy